Use of duplex PCR-CTPP methods for CYP2E1 RsaI/IL-2 T-330G and IL-1B C-31T/TNF-A T-1031C polymorphisms

Molecular Diagnosis

Volumn 9, Issue 2, 2005, Pages 89-94

  Atsuta, Yoshiko ^a   Kawase, Haruya ^b   Hamajima, Nobuyuki ^a   Nishio, Kazuko ^a   Niwa, Yoshimitsu ^a   Tanaka, Daisuke ^a   Yamamoto, Kazuhito ^a   Tamakoshi, Akiko ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2E1; DNA; INTERLEUKIN 1BETA; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 1; PRIMER DNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; GENE DELETION; GENETICS; METHODOLOGY; MIDDLE AGED; RESTRICTION MAPPING; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CYTOCHROME P-450 CYP2E1; DNA PRIMERS; FEMALE; HUMANS; INTERLEUKIN-1; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RESTRICTION MAPPING; SEQUENCE DELETION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 27744557551     PISSN: 10848592     EISSN: 10848592     Source Type: Journal    
DOI: 10.2165/00066982-200509020-00005     Document Type: Article

References (40)

1. Hamajima N, Saito T, Matsuo K, et al. Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res 2000 Sep; 91 (9): 865-8
2. Hamajima N. PCR-CTPP: a new genotyping technique in the era of genetic epidemiology. Expert Rev Mol Diagn 2001 May; 1 (1): 119-23
3. Hamajima N, Saito T, Matsuo K, et al. Competitive amplification and unspecific amplification in polymerase chain reaction with confronting two-pair primers (PCR-CTPP). J Mol Diagn 2002 May; 4 (2): 103-7
4. Hamajima N, Saito T, Matsuo K, et al. Genotype frequencies for 50 polymorphisms for 241 Japanese non-cancer patients. J Epidemiol 2002 May; 12 (3): 229-36
5. Atsuta Y, Hamajima N. A new genotyping method, PCR-CTPP [in Japanese]. Rinsho Byori 2003 Sep; 51 (9): 886-91
6. Tamakoshi A, Hamajima N, Kawase H, et al. Duplex polymerase chain reaction with confronting two-pair primers (PCR-CTPP) for genotyping alcohol dehydrogenase B subunit (ADH2) and aldehyde dehydrogenase (ALDH2). Alcohol 2003 Sep-Oct; 38 (5): 407-10
7. Kawase H, Hamajima N, Tamakoshi A, et al. Triplex polymerase chain reaction with confronting two-pair primers (PCR-CTPP) for NQO1 C609T, GSTM1, and GSTT1 polymorphisms: the most convenient genotyping method. Asian Pac J Cancer Prev 2003 Jan-Mar; 4 (1): 67-70
8. Hayashi S, Watanabe J, Kawajiri K. Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 1991 Sep; 110 (3): 559-65
9. Kato S, Shields PG, Caporaso NE, et al. Cytochrome P450IIEI genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res 1992 Dec; 52 (23): 6712-5
10. Wu X, Shi H, Jiang H, et al. Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carci-nogenesis 1997 May; 18 (5): 967-73
11. Le Marchand L, SIvaraman L, Pierce L, et al. Association of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 1998 Nov; 58 (21): 4858-63
12. Bouchardy C, Hirvonen A, Coutelle C, et al. Role of alcohol dehydrogenase 3 and cytochrome p-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract. Int J Cancer 2000 Sep; 87 (5): 734-40
13. Lin DX, Tang YM, Peng Q, et al. Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferase T1, P1, and M1 and cytochrome P450 2E1. Cancer Epidemiol Biomarkers Prev 1998 Nov; 7 (11): 1013-8
14. Tan W, Song N, Wang GQ, et al. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferase M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol Biomarkers Prev 2000 Jun; 9 (10): 551-6
15. Yu MW, Gladek-Yarborough A, Chiamprasert S, et al. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellu-lar carcinoma. Gastroenterology 1995; 109: 1266-73
16. Choi JY, Lee KM, Cho SH, et al. CYP2E1 and NQO1 genotypes, smoking and bladder cancer. Pharmacogenetics 2003 Jun; 13 (6): 349-55
17. Hung HC, Chuang J, Chien YC, et al. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1: environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev 1997 Nov; 6 (11): 901-5
18. Hildesheim A, Anderson LM, Chen CJ, et al. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 1997 Aug; 89 (16): 1207-12
19. Ladero JM, Agundez JA, Rodriguez-Lescure A, et al. RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma. Gut 1996 Aug, 3
20. Mattias C, Bockmuhl U, Jahnke V, et al. Polymorphism in cytochrome P 450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics 1998; 8: 91-100
21. Morita S, Yano M, Shiozaki H, et al. CYP1A1, CYP2E1 and GSTM1 polymorph-isms are not associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 1997 Apr; 71 (2): 192-5
22. Kato S, Onda M, Matsukura N, et al. Cytochrome P4502E1 (CYP2E1) genetic polymorphism in a case-control study of gastric cancer and liver disease. Pharmacogenetics 1995; 5: S141-4
23. Nishimoto I, Hanaoka T, Sugimura H, et al. Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil: case control studies of Japanese Brazilians and non-Japanese Brazilians. Cancer Epidemiol Biomarkers Prev 2000 Jul; 9 (7): 675-80
24. Gao C, Takezaki T, Wu J, et al. Interaction between cytochrome P-450 2E1 polymorphisms and environmental factors with risk of esophageal and stomach cancers in Chinese. Cancer Epidemiol Biomarkers Prev 2002 Jan; 11 (1): 29-34
25. Persson I, Johansson I, Bergling H, et al. Genetic polymorphism of cytochrome P4502E1 in a Swedish population: relationship to incidence of lung cancer. FEBS Lett 1993 Mar; 319 (3): 207-11
26. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, et al. The human CYP2E1 gene and lung cancer: DraI and RsaI restriction fragment length polymorphisms in a Finnish study population. Carcinogenesis 1993 Jan; 14 (1): 85-8
27. Watanabe J, Yang J-P, Eguchi H, et al. An Rsa I polymorphism in the CYP2E1 gene does not affect lung cancer risk in a Japanese population. Jpn J Cancer Res 1995 Mar; 86 (3): 245-8
28. London SJ, Daly AK, Cooper J, et al. Lung cancer risk in relation to the CYP2E1 RsaI genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California. Pharmacogenetics 1996 Apr; 6 (2): 151-8
29. Anwar WA, Abdel-Rahman SZ, El-Zein RA, et al. Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients. Carcinogenesis 1996 Sep; 17 (9): 1923-9
30. Hakkola J, Hu Y. Ingelman-Sundberg M. Mechanisms of down-regulation of CYP2E1 expression by inflammatory cytokines in rat hepatoma cells. J Pharmacol Exp Ther 2003 Mar; 304 (3): 1048-54
31. Elkahwaji J, Robin MA, Berson A, et al. Decrease in hepatic cytochrome P450 after interleukin-2 immunotherapy. Biochem Pharmacol 1999 Apr; 57 (8): 951-4
32. Tindberg N, Baldwin HA, Cross AJ, et al. Induction of cytochrome P450 2E1 expression in rat and gerbil astrocytes by inflammatory factors and ischemic injury. Mol Pharmacol 1996 Nov; 50 (5): 1065-72
33. Tinel M, Robin MA, Doostzadeh J, et al. The interleukin-2 receptor down regulates the expression of cytochrome P450 in cultured rat hepatocytes. Gastroenterology 1995 Nov; 109 (5): 1589-99
34. Peng HM, Coon MJ. Promoter function and the role of cytokines in the transcriptional regulation of rabbit CYP2E1 and CYP2E2. Arch Biochem Biophys 2000 Oct; 382 (1): 129-37
35. Dianarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095-147
36. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer [published erratum appears in Nature 2001 Jul; 412 (6842): 99]. Nature 2000 Mar; 404 (6776): 398-402
37. Hamajima N, Matsuo K, Saito T, et al. Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection. Jpn J Cancer Res 2001 Apr; 92 (4): 383-9
38. Matesanz F, Fedetz M, Collado-Romero M, et al. Allelic expression and interleukin-2 polymorphisms in multiple sclerosis. J Neuroimmunol 2001 Sep; 119 (1): 101-5
39. Scarel-Caminaga RM, Trevilatto PC, Souza AP, et al. Investigation of an IL-2 polymorphism in patients with different levels of chronic periodontitis. J Clin Periodontol 2002 Jul; 29 (7): 587-91
40. Kamizono S, Hiromatsu Y, Seki N, et al. A polymorphism of the 5' flanking region of tumour necrosis factor a gene is associated with thyroid-associated ophthalmopathy in Japanese. Clin Endocrinol 2000 Jun; 52 (6): 759-64